Cellular model system to dissect the isoform-selectivity of Akt inhibitors von Quambusch, Lena, Depta, Laura, Landel, Ina, Lubeck, Melissa, Kirschner, Tonia, Nabert, Jonas, Uhlenbrock, Niklas, Weisner, Jörn, Kostka, Michael, Levy, Laura M., Schultz-Fademrecht, Carsten, Glanemann, Franziska, Althoff, Kristina, Müller, Matthias P., Siveke, Jens T., Rauh, Daniel

Volltext

Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors von Goebel, Lisa, Kirschner, Tonia, Koska, Sandra, Rai, Amrita, Janning, Petra, Maffini, Stefano, Vatheuer, Helge, Czodrowski, Paul, Goody, Roger S, Müller, Matthias P, Rauh, Daniel

Volltext

Targeting KRAS Diversity: Covalent Modulation of G12X and Beyond in Cancer Therapy von Kirschner, Tonia, Müller, Matthias P., Rauh, Daniel

Volltext

Targeting Her2-insYVMA with Covalent InhibitorsA Focused Compound Screening and Structure-Based Design Approach von Lategahn, Jonas, Hardick, Julia, Grabe, Tobias, Niggenaber, Janina, Jeyakumar, Kirujan, Keul, Marina, Tumbrink, Hannah L, Becker, Christian, Hodson, Luke, Kirschner, Tonia, Klövekorn, Philip, Ketzer, Julia, Baumann, Matthias, Terheyden, Susanne, Unger, Anke, Weisner, Jörn, Müller, Matthias P, van Otterlo, Willem A. L, Bauer, Sebastian, Rauh, Daniel

Volltext